• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Sunday, June 7, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

AP

Nobel Prize in medicine goes to 3 for work on human immune system

Published on: October 7, 2025 1:40 AM

Mary E. Brunkow, Fred Ramsdell and Dr. Shimon Sakaguchi won the Nobel Prize in medicine on Monday for their discoveries concerning peripheral immune tolerance.

Brunkow, 64, is a senior program manager at the Institute for Systems Biology in Seattle. Ramsdell, 64, is a scientific adviser for Sonoma Biotherapeutics in San Francisco. Sakaguchi, 74, is a distinguished professor at the Immunology Frontier Research Center at Osaka University in Japan.

The immune system has many overlapping systems to detect and fight bacteria, viruses and other bad actors. Key immune warriors such as T cells get trained on how to spot bad actors. If some instead go awry in a way that might trigger autoimmune diseases, they´re supposed to be eliminated in the thymus – a process called central tolerance.

The Nobel winners unraveled an additional way the body keeps the system in check.

The Nobel Committee said it started with Sakaguchi´s discovery in 1995 of a previously unknown T cell subtype now known as regulatory T cells or T-regs.

Then in 2001, Brunkow and Ramsdell discovered a culprit mutation in a gene named Foxp3, a gene that also plays a role in a rare human autoimmune disease.

The Nobel Committee said two years later, Sakaguchi linked the discoveries to show that the Foxp3 gene controls the development of those T-regs – which in turn act as a security guard to find and curb other forms of T cells that overreact.

The work opened a new field of immunology, said Karolinska Institute rheumatology professor Marie Wahren-Herlenius. Researchers around the world now are working to use regulatory T cells to develop treatments for autoimmune diseases and cancer.

“Their discoveries have been decisive for our understanding of how the immune system functions and why we do not all develop serious autoimmune diseases,” said Olle Kämpe, chair of the Nobel Committee.

Thomas Perlmann, Secretary-General of the Nobel Committee, said he was only able to reach Sakaguchi by phone Monday morning.

“I got hold of him at his lab and he sounded incredibly grateful, expressed that it was a fantastic honor. He was quite taken by the news,” Perlmann said. He added that he left voicemails for Brunkow and Ramsdell.

Filed Under: World Tagged With: human immune system, Mary E. Brunkow, Nobel prize

Submit a Comment




Primary Sidebar




Latest News

Mirra Andreeva wins French Open to claim first Grand Slam title

Antonelli pips Verstappen to Monaco pole

Iran World Cup squad heads to Mexico as US visa row erupts

Bosnia’s World Cup pursuit begins at a home-away-from home in the American Midwest

Football fans urge red card for coach who led Israeli club

Pakistan

All set for Gilgit-Baltistan Elections today

Mohsin Naqvi arrives in Tehran as Pakistan pushes for US-Iran deal

Lebanon army chief visits US-Iran mediator Pakistan

US strikes Iranian sites after Iran launches drones, in latest Gulf flare-up

72 held in AJK crackdown as government defends JAAC ban

More Posts from this Category

Business

PSX new IPOs deliver 47% average return, boosting investor confidence

Pakistan signs MoU with Saudi, local firms to develop Karachi maritime business district

Gold prices witness sharp decline

Gul Ahmed venture QGDC announces $230m investment to set up Pakistan’s largest data centre

SECP takes action against 36 government entities

More Posts from this Category

World

Trump claims Iran missile stockpile shrinking

Young ‘cockroaches’ hold first protest in New Delhi

Ukraine strikes key Russian military sites

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.